UndisclosedDivestiture / carve-outHealthcare & Life Sciences
Charles River to buy Frontage's bioanalysis and DMPK businesses
Charles River Laboratories, based in Wilmington, Massachusetts, announced it will acquire the bioanalysis and DMPK businesses of Frontage. No financial terms were provided in the announcement.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Following healthcare M&A?
The day's biggest deals, healthcare included, in one five-minute email every morning. Built for dealmakers and investors. Free, with no paywalled links.
See what you get →